Basal insulin analogues similar for glucose lowering
(HealthDay)—Basal insulin analogues for type 2 diabetes mellitus (T2DM) do not substantially differ in their glucose-lowering effect, according to a review published online July 10 in the Annals of Internal Medicine.
Jul 18, 2018
0
0